KIDNEY NEOPLASMS
Clinical trials for KIDNEY NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new KIDNEY NEOPLASMS trials appear
Sign up with your email to follow new studies for KIDNEY NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney cancer combo trial halted early – what we know
Disease control TerminatedThis study tested two new drug combinations for people with advanced clear cell kidney cancer that had already been treated. The goal was to see if adding the experimental drug NKT2152 to standard therapies could shrink tumors or slow the disease. The trial was stopped early, so …
Matched conditions: KIDNEY NEOPLASMS
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New pill shows promise in halting advanced kidney cancer growth
Disease control TerminatedThis trial tested an oral drug called NKT2152 for people with advanced clear cell kidney cancer that has worsened after other treatments. The drug works by blocking a protein that helps cancer grow. The study aimed to find the safest dose and see if it can shrink tumors or slow t…
Matched conditions: KIDNEY NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Radiation therapy study seeks immune clues for better cancer treatment
Knowledge-focused TerminatedThis study looked at how the immune system responds during high-dose radiation therapy in people with liver, colorectal, melanoma, or kidney cancers. Researchers collected blood samples before, during, and after treatment to track immune cells and other markers. The goal was to l…
Matched conditions: KIDNEY NEOPLASMS
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC